NATIONAL CLINICAL TRIAL NETWORK

In response to persistent disparities in clinical trial inclusion of Black and African Americans (BAAs), NABONC is committed to increasing African American representation among participants and principal investigators. We advocate for AA interests and support culturally sensitive drug development by (1) providing consultation throughout the drug development process and (2) building a collaborative network of research sites focused on conducting impactful, cancer-related clinical trials to advance health equity.

Expanding a National Collaboration

NABONC’s current network of 9 sites across five states now include:

Massachusetts, Pennsylvania, Virginia, Alabama, and Mississippi.

We are interested in building alliances to construct the perfect mix of large community treatment centers, mid-size hospital systems, and academic institutions that will support our aims of advancing health equity for Black and African American health consumers.

Current Network of Domestic Collaboration

Ranked Priorities

  • Early (Study Design) Advocacy For BAA Patients

    Patients First. NABONC seeks to join in early phases of study development to provide voice for the BAA spectrum of communities.

    Drug developers may contact us to learn more.

    Contact Us

  • Increase Our Inclusion In Appropriate and Relevant Trials

    Championed and practically accompanied, BAA patients can enter clinical trials with confidence.

    For NABONC certified trials, BAAs may also contact us for educational support related to their trial and condition.

  • Improve Efficiency Of Study Initiation

    Through designated centers, our network enables faster initiation of trials so patients may gain access and begin participating with little to no delay.

  • Support Trial Sites, Researchers, and Clinicians

    As an advocate for patients and communities, NABONC provides support to institutions and clinicians to ensure that they have the support and resources needed to protect and support their BAA trial participants.

    Become A Clinical Trial Site

“Culturally sensitive, should be the only manner in which healthcare provisions are administered.”

— NABONC